DRTS:NASDAQ, Alpha Tau Medical Ltd.

DRTS stock overview

Alpha Tau Medical Ltd. (DRTS:NASDAQ) closed at $13.70 on November 10, 2026, down 2.91% on the day. The stock trades 13.2% below its 52-week high of $15.79 and 299.4% above its 52-week low of $3.43. Over the past year, it gained 258.1%. Alpha Tau Medical Ltd. is part of the Health Care sector.

Key figures

Price
$13.70
Day change
-2.91%
Volume
426,928
Average volume
542,640
Market cap
1B+
52-week range
$3.43 – $15.79
50-day average
$14.12
200-day average
$10.80

Price action over the past year

In 252 trading sessions since November 10, 2025, DRTS closed higher on 130 days (52%). Its best day was May 11, 2026 (+21.50%) and its worst was May 4, 2026 (-11.83%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

DRTS news

About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors.

Similar stocks

Find more stocks like DRTS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.